BernardRRubinDOMPH

Rheumatology • Traverse City, MI

Lupus & Related, Vasculitis

Medical Expert Immunology and Rare Diseases, GSK.

Join to view full profile

Dr. Rubin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rubin's full profile

Already have an account?

Office
0000
Traverse City, MI 49684
Phone+1 248-496-1422

Education & Training

Drexel University College of Medicine/Hahnemann UniversityFellowship, Immunology, 1982 - 1983
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Rheumatology, 1981 - 1982
Albert Einstein Healthcare NetworkFellowship, Rheumatology, 1980 - 1981
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1977 - 1980
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1976

Certifications & Licensure

MI State License 2010 - 2026
TX State License 1983 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

National Top Doctor Castle Connolly, 1996-2018
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACR) American College of Rheumatology
Join now to see all

Publications & Presentations

PubMed

115 citations
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial
Bernard R. Rubin, Robert Burton, Sandra V. Navarra, Joseph Antigua, John Londoño
Arthritis and Rheumatism. 2004-02-01
91 citations
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferi...
Clifton O. Bingham, A. I. Sebba, Bernard R. Rubin, Gary E. Ruoff, Joel M. Kremer
Rheumatology. 2007-03-01
15 citations
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
Steven S. Smugar, Thomas J. Schnitzer, Arthur L. Weaver, Bernard R. Rubin, Adam B. Polis
Current Medical Research and Opinion. 2006-06-08

Professional Memberships

American Osteopathic Association - AOA
Member
American College of Rheumatology - ACR
Fellow
American College of Osteopathic Internists - ACOI
Fellow
American College of Physicians - ACP
Fellow

Industry Relationships

US Immunology Medical Expert, GSK2018 - Present